PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6.38%
Negative net income growth while ORCL stands at 55.98%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.67%
Both reduce yoy D&A, with ORCL at -2.38%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
60.56%
Well above ORCL's 100.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-109.45%
Both reduce yoy usage, with ORCL at -161.96%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-100.00%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-112.74%
Both reduce yoy usage, with ORCL at -161.96%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-48.77%
Negative yoy while ORCL is 68.42%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-55.17%
Both yoy CFO lines are negative, with ORCL at -79.39%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-72.50%
Negative yoy CapEx while ORCL is 25.58%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
98.97%
Acquisition growth of 98.97% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
27.28%
Some yoy expansion while ORCL is negative at -147.28%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-34.10%
We reduce yoy sales while ORCL is 40.56%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-125.08%
Both yoy lines negative, with ORCL at -151.29%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while ORCL is 290.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
73.23%
We have some buyback growth while ORCL is negative at -22.27%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.